Imugene share price
WebOver the last 12 months, Imugene 's shares have ranged in value from as little as $0.125 up to $0.315. A popular way to gauge a stock's volatility is its "beta". IMU.AU volatility (beta: 2.06) Avg. volatility (beta: 1.00) Low High Beta measures a share's volatility in … WebMay 26, 2024 · It has no revenue or products and is at the clinical trial stage, but reached an incredible $2.3 billion market-cap based on a 47¢ share price on Wednesday. Imugene …
Imugene share price
Did you know?
WebApr 10, 2024 · Newmont offered Newcrest shareholders more shares and a short-term cash sweetener under an improved bid that Newcrest said valued its shares at $32.87. Newcrest said the deal represented a 46.4 per... WebApr 12, 2024 · Imugene - IMU Stock Forecast, Price & News Compare Today's Range N/A 50-Day Range N/A 52-Week Range N/A Volume 12.70 million shs Average Volume N/A …
WebAug 25, 2024 · Its share price surged over 20x in less than 24 months – from 3c in early 2024 to 67c by November 2024 – taking the valuation to an eye-watering $3.3 billion and earning the company ‘unicorn’ status. It also made Imugene the second-biggest ASX drug developer by market cap, behind only CSL. WebImugene is a clinical-stage immuno-oncology company developing cancer treatments. Founding Date. Founding Date. 2010. Founding Date. 2024. Founding Date. 2002. Founding Date. 2024. Founding Date. 2013. Type. ... Share price data provided by IEX. Company directory. Search directory ...
WebImugene is a clinical stage immuno-oncology company developing a range of new treatments that seek to activate the immune system of cancer patients to identify and … WebImugene is a publicly traded company, listed on the Australian Securities Exchange (ASX) under the code IMU. In December 2024 it entered the S&P/ASX 200 Index, in effect making …
WebJun 4, 2024 · Replimune currently has a market cap of US$ 740 million, $20.15 per share, so over $1 billion Aussie. Replimune currently has broker research /price targets of between $22 -$30 per share from analysts at JPMorgan, Roth Capital, Wainwright, Barclays . Ie median valuation of US$870 million
Web2 days ago · I agree with your sentiment @Watmighthavben and share your intrigue at the languishing share price. I hold another little medical company in the X-Ray field with a similar graph to your examples, jumping from circa 30c on 3rd April touching around 95c today because of a couple of recent announcements. how to get target redcardWebPrice: Single User License: US $ 3260 . Corporate User License: US $ 6520 . Buy Now. Like . Inquire for Discount Download PDF Request Sample. Report Description; Table of Contents; The Nucleic Acid-based Drugs market revenue was XX Million USD in 2024, and will reach XX Million USD in 2028, with a CAGR of XX% during 2024-2028. john pass village and boardwalk hotelsWebApr 7, 2024 · Imugene - IMU News Today Compare Today's Range N/A 50-Day Range N/A 52-Week Range N/A Volume 12.70 million shs Average Volume N/A Market Capitalization N/A P/E Ratio N/A Dividend Yield N/A Price Target N/A Profile Chart Competitors Insider Trades Headlines Get Imugene News Delivered to You Automatically how to get target security tag off clothesWebJul 27, 2024 · Since March the company has surged from a share price of only 10¢ to 33¢, having climbed as high as 50¢ in May. Despite still being pre-revenue, the business is now valued at $1.6 billion. how to get target red cardWebImugene Ltd. Watch list Create IUGNF Alert Closed Last Updated: Jan 27, 2024 9:32 a.m. EST Delayed quote $ 0.1075 -0.0026 -2.36% Previous Close $0.1101 Advanced Charting … john paste waxWebFind the latest Imugene Limited (IMU.AX) stock quote, history, news and other vital information to help you with your stock trading and investing. how to get tarkov gift from fenceWebJul 29, 2024 · The share price represents a 9.1% discount to the closing price of IMU shares on July 26 and a 10% discount to the five-day volume-weighted average price up to and including that same date. how to get target heart rate